Very good! Finally found some reasonable guys. Many others expect fast money on next hours, wth? I shared my findings. May the forces with us. Let's roll and make another Bintai and Solution!
For the benefit of members who have bought in at a high and are stuck with Bintai or Solution, I have considered 2 hedging glove-related stocks with proven fundamentals and profits:
DANONCE TECHNOLOGY (7114) SAMCHEM (5147)
Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.
From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.
Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0
Samchem is a chemicals company supplying chemicals to glove companies to manufacture gloves. Also a solid company with strong fundamentals and growing profits. TP by analyst: 1.23
This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.
Please note that the idea of hedging is meant to counter the turbulence of the pharma stocks and the market. I still continue to believe Bintai has its own potential upside but with market sentiments swaying, it would be advisable to not put all your eggs in one basket. At the same time, I do not advocate speculating in penny stocks. My definition of penny stocks are stocks with no proven track record and are trading at ridiculous prices relative to their profits.
I only would advocate hedging stocks with the following criteria:
1. proven track record and profit growth. 2. strong management team and visible corporate earnings, 3. transparent management ideas such as presentations and press releases so we know what is going on with the company. 4. glove related preferably as glove demand will continue to be elevated. 5. strong fundamentals and relatively low PE ratio 6. current price still demonstrates an upside (massive upside 30% or more) and not over-priced so that there is still gain to be made without investors taking ridiculous risks.
They said Bursa Malaysia would not be dragged down if investors were to switch from glove counters to other sectors.
The likes of AmBank Research expects the ASPs to begin tapering off in the first quarter (Q1) of 2021, while CGS-CIMB views the downside risks for the glove manufacturer included the discovery of the Covid-19 vaccine.
CGS-CIMB analyst Walter AW said this would lead to weak sentiment for the stocks and stiffer-than-expected pricing competition.
AmBank Research said the share prices of most glove companies had exceeded its target prices.
This prompted the firm to downgrade its call on the glove sector from "overweight" to "neutral",. (Read News Straits Time 28 Aug 2020). It is just less than one or two month for all investors to switch from glove counters to other sector (Eg. Vaccine).
Sell all glove stock that you have earned. I have made my switch since mid of Aug. I was trading in Glove Counters as well. Is time to change and look on "greater" potential stock. Those glove stock is already >300% -500%, some even 1000%, would you expect another 1000%? If yes, that will only happen in Vaccine Stock for now.
Futhermore, you may observe how many joint venture/ new into glove business by only this few months. It is same as the moment we saw lot of new cafe set up, lot of new bubble tea shops open, lot of finger fried Korean Chicken due to the sudden "need and attention". It always come to end very soon. Those joined at last ship will dive. For me, you are joining last ship for glove now. It will sail forever with the same price and speed until it drop drastically with the continuous update from Vaccine. Hope you see what I mean here and I do respect all opinion. Thanks.
Guess what. Mco will help on Vaccine stock instead. Ppl getting frustrated and eagerly hope for CURE from any country. Wow. China gonna shot 2nd gun after Russia? Next trading day will be red Sea for glove stock again while Solution will catch up? XD
What the hell got sifu like this.. Too bad. So the truth is they already sold Glove and buy vaccines instead? Guys, sell all Glove as fast as you can and hold Bintai and Solution. Whichever done first also can, China serve Middle East, China, Asia, while US serve Europe, and some other Asia. No contradict in market.
Sure things. Tuesday is show time of vaccine stocks. Both Bintai and Solution will soar! Menort, please top up more in glove stock. I can see all this sifu and fake sifu are secretly/openly dumped their stock and keep asking others to buy their dumped price. Whree all this sifu and fake sifu go? Sure Bintai and Solution! They will comenout after 100percent gain soon!
China vaccine was approved for emergency used for Frontline. Russia vaccine was approved too!
The next US or EU vacvine approval will trigger the super rally for vaccine stocks from pharma, dpharma as leader (like top glove and Supermx) Bintai and solution (like hlt and careplus)
Quickly go and check, Those investment com and fake sifu will tell you dmand of glove is still there. In fact, They all sold it secretly before you know. God damn! Sell all Glove now! Will drop a lot next week, worst is go back to original price. Is pure goreng for glove stock now. Only Ambank is honest and earn our respect. Ambank already downgraded glove stock and published it! Ambank said glove has reached their limit!
Chinese pharmaceutical maker in talks for early Covid-19 vaccine approval
(Aug 29): Chinese pharmaceutical maker CanSino Biologics Inc is in talks with several countries to allow its coronavirus vaccine that’s in development to be used on small groups of people before large-scale safety and effectiveness trials are completed, the Wall Street Journal reported.
The company is speaking to Pakistan, several Latin America countries and some developed nations, the paper said, citing Pierre Morgon, senior vice president for international business at CanSino. Doses could be administered to health-care and other frontline workers if emergency approval is granted, the report said, adding that none have agreed to allow it yet.
The Chinese military has permitted the use of the CanSino vaccine before the completion of large-scale final testing, the report said, citing a company filing.
NOTE : Doses could be administered to health-care and other frontline workers if emergency approval is granted, the report said, adding that none have agreed to allow it yet.
Sinovac's coronavirus vaccine candidate approved for emergency use in China — source Roxanne Liu / Reuters
August 29, 2020 19:54 pm +08
State media Xinhua reported late on Friday that two vaccine candidates were approved in June for the emergency use program launched in July, without identifying the specific products.
Officially, China has given little details on which vaccine candidates have been given to high-risk people under the emergency use programme and how many people have been vaccinated.
In June, prior to the emergency use programme, employees at state firms travelling overseas were allowed to take one of the two vaccines being developed by CNBG, state media Global Times reported. China's military had also approved the use of CanSino Biologics' vaccine candidate.
Seven vaccines against the coronavirus are in final trial stages around the world, and four of them are from China.
But no vaccine has yet passed the final stage of trials proving it is safe and effective — conditions usually required to be met to get regulatory approval for mass use. Covid-19 has killed over 800,000 people worldwide.
NOTE:But no vaccine has yet passed the final stage of trials proving it is safe and effective — conditions usually required to be met to get regulatory approval for mass use. Covid-19 has killed over 800,000 people worldwide.
Wa.. Seems like there is party here. Why all keep spamming. Promote is not like this. Share great news and happiness pls.. Dont tease and judge others. Anyway, minimum Rm1. 2 for Bintai and Solution next week. Buy and get profit. Don't miss the boat!
Bintai will limit down 2 days next week n back to below 0.10 again All holders should cut loss immediately or else will burnt to hell Very obvious is a highly speculated stock by shark n syndicate All vaccine news are fraud n trick u all ikan bilis
Sinovac's coronavirus vaccine candidate approved for emergency use in China — source Roxanne Liu / Reuters
August 29, 2020 19:54 pm +08
State media Xinhua reported late on Friday that two vaccine candidates were approved in June for the emergency use program launched in July, without identifying the specific products
NOTE:But no vaccine has yet passed the final stage of trials proving it is safe and effective — conditions usually required to be met to get regulatory approval for mass use. Covid-19 has killed over 800,000 people
(Aug 29): Chinese pharmaceutical maker CanSino Biologics Inc is in talks with several countries to allow its coronavirus vaccine that’s in development to be used on small groups of people before large-scale safety and effectiveness trials are completed, the Wall Street Journal reported.
The company is speaking to Pakistan, several Latin America countries and some developed nations
NOTE : Doses could be administered to health-care and other frontline workers if emergency approval is granted, the report said, adding that none have agreed to allow it yet.
pharma duopharma,bintai,solution confirm is a con counter la, no real stock on hand no production no profit (extra profit generate from vaccine) no nothing people goreng like no tomorrow... sor hai
Guys. vaccine counter is just mainly in packaging for vaccine which produce by other countries. but not the one to produce vaccine, summore the stock price for vaccine counter is overvalued and they don't even come out with any positive result. please think about it before invest in vaccine counter.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
WarrenL
114 posts
Posted by WarrenL > 2020-08-28 20:45 | Report Abuse
Pang, join the force? lol